Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for CHINA CRSC?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2016–2025
Financial statements are reported in CNY, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from CN¥29.40B in FY2016 to CN¥34.55B in FY2025 (9-year CAGR +1.8%).
- Profitable in every fiscal year across 2016–2025.
- Operating cash flow was below half of net income in FY2017, FY2018, FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (CNY B) | 38.4 | 40.2 | 37.0 | 32.5 | 34.6 |
| YoY | -4.4% | 4.8% | -8.0% | -12.2% | 6.4% |
| Net Income (CNY B) | 3.27 | 3.63 | 3.48 | 3.49 | 3.69 |
| YoY | -14.3% | 11.0% | -4.3% | 0.5% | 5.5% |
| Operating Cash Flow (CNY B) | 2.77 | 2.08 | 2.06 | 5.24 | -1.29 |
| ROE | 7.6% | 8.2% | 7.5% | 7.4% | 7.5% |
| Gross Margin | 22.2% | 23.7% | 25.6% | 29.2% | 28.9% |
| Net Margin | 8.5% | 9.0% | 9.4% | 10.8% | 10.7% |
| Debt-to-Assets | 58.4% | 59.5% | 58.9% | 57.2% | 55.7% |
Show all 10 fiscal years
| Fiscal Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (CNY B) | 29.4 | 34.4 | 40.0 | 41.6 | 40.1 | 38.4 | 40.2 | 37.0 | 32.5 | 34.6 |
| YoY | — | 17.1% | 16.2% | 4.1% | -3.7% | -4.4% | 4.8% | -8.0% | -12.2% | 6.4% |
| Net Income (CNY B) | 3.05 | 3.31 | 3.41 | 3.82 | 3.82 | 3.27 | 3.63 | 3.48 | 3.49 | 3.69 |
| YoY | — | 8.5% | 3.0% | 12.0% | 0.1% | -14.3% | 11.0% | -4.3% | 0.5% | 5.5% |
| Operating Cash Flow (CNY B) | 2.94 | -0.89 | -1.59 | 3.37 | 3.01 | 2.77 | 2.08 | 2.06 | 5.24 | -1.29 |
| ROE | — | — | 11.8% | 10.9% | 9.1% | 7.6% | 8.2% | 7.5% | 7.4% | 7.5% |
| Gross Margin | 25.3% | 24.4% | 22.7% | 22.9% | 22.1% | 22.2% | 23.7% | 25.6% | 29.2% | 28.9% |
| Net Margin | 10.4% | 9.6% | 8.5% | 9.2% | 9.5% | 8.5% | 9.0% | 9.4% | 10.8% | 10.7% |
| Debt-to-Assets | — | — | 62.0% | 56.2% | 57.9% | 58.4% | 59.5% | 58.9% | 57.2% | 55.7% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
-
Alert
Cash ConversionFinancial Quality
OCF / Net Income: FY2025 (2025-12-31) -0.35, FY2024 (2024-12-31) 1.50
FY2025 (ended 2025-12-31) · What is this?
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
Trailing 12-month dividend: HK$0.195 per share, or 6.50% yield at closing price; last full fiscal year: HK$0.195 (payout ratio 53.3%).
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.